Target intelligence / Profile preview

Endogenous nitrate- and nitrite-reducing enzymatic systems (Nitrate-nitrite-NO pathway)

Target
Nitrate-nitrite-NO pathway
Molecular classification
Enzyme, Oxidoreductase, Metalloenzyme, Heme protein
01

Overview

The endogenous nitrate- and nitrite-reducing enzymatic systems constitute a secondary pathway for nitric oxide (NO) production that operates independently of the oxygen-dependent nitric oxide synthase (NOS) enzymes (Lundberg et al., 2008). This pathway involves the sequential reduction of nitrate to nitrite, primarily by commensal oral bacteria, and the subsequent reduction of nitrite to NO by various mammalian proteins (Gladwin et al., 2005). Key enzymes and proteins involved in this process include xanthine oxidoreductase, deoxyhemoglobin, deoxymyoglobin, and certain mitochondrial enzymes (Weitzberg et al., 2010). A unique feature of this system is that its activity is significantly enhanced under conditions of hypoxia and low pH, where the conventional NOS pathway is often impaired (Zweier et al., 1995). In disease states such as hypertension, myocardial infarction, and peripheral artery disease, these systems serve as a crucial backup for maintaining NO bioavailability and vascular homeostasis (Hord et al., 2009). Therapeutic interventions often involve the administration of inorganic nitrate or nitrite salts to provide substrates for these enzymes, thereby promoting vasodilation and cytoprotection. Research into these systems has expanded the understanding of how dietary nitrate influences cardiovascular health and exercise performance. However, pharmacological targeting must be carefully managed to avoid excessive NO production or the formation of methemoglobin.

Other names
Nitrate-nitrite-nitric oxide pathwayMammalian nitrate and nitrite reductasesNon-canonical nitric oxide synthesis pathwayNitrate reductase systemNitrite reductase system
02

Mechanism of action

The primary mechanism involves the enzymatic reduction of inorganic nitrate to nitrite and then to nitric oxide (NO), providing an alternative source of NO that is particularly active during hypoxia and acidosis, thereby bypassing dysfunctional nitric oxide synthase (NOS) pathways (Lundberg et al., 2008).

03

Biological functions

Nitric oxide signalingVasodilationRegulation of mitochondrial respirationIschemic protectionBlood pressure regulationCytoprotection
04

Disease associations

Cardiovascular diseaseHypertensionIschemia-reperfusion injuryHeart failurePeripheral arterial diseaseMetabolic syndromeType 2 diabetes
05

Safety considerations

MethemoglobinemiaSevere hypotensionPotential for N-nitrosamine formationDrug-drug interactions with phosphodiesterase-5 inhibitorsThyroid function interference at high doses
06

Interacting drugs

Sodium nitrate

5 more in the full profile.

07

Biomarkers

Plasma nitrite concentrationPlasma nitrate concentrationMethemoglobin levelsBlood pressureFlow-mediated dilation (FMD)Exhaled nitric oxide

Beyond the preview

Go deeper on Endogenous nitrate- and nitrite-reducing enzymatic systems (Nitrate-nitrite-NO pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous nitrate- and nitrite-reducing enzymatic systems (Nitrate-nitrite-NO pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call